[PDF][PDF] Clinical guidelines for the management of adrenal incidentaloma

JM Lee, MK Kim, SH Ko, JM Koh… - Endocrinology and …, 2017 - synapse.koreamed.org
An adrenal incidentaloma is an adrenal mass found in an imaging study performed for other
reasons unrelated to adrenal disease and often accompanied by obesity, diabetes, or …

Systematic review of surgery and outcomes in patients with primary aldosteronism

A Muth, O Ragnarsson, G Johannsson… - Journal of British …, 2015 - academic.oup.com
Background Primary aldosteronism (PA) is the most common cause of secondary
hypertension. The main aims of this paper were to review outcome after surgical versus …

[HTML][HTML] 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension

TD Wang, CE Chiang, TH Chao, HM Cheng… - Acta Cardiologica …, 2022 - ncbi.nlm.nih.gov
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …

7th Brazilian Guideline of Arterial Hypertension: Presentation

MVB Malachias - Arquivos brasileiros de cardiologia, 2016 - SciELO Brasil
On behalf of the Brazilian Society of Cardiology, Brazilian Society of Hypertension and
Brazilian Society of Nephrology, I present to you the 7th Brazilian Guideline of Arterial …

Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands

K Nishimoto, SA Tomlins, R Kuick… - Proceedings of the …, 2015 - National Acad Sciences
Primary aldosteronism (PA) represents the most common cause of secondary hypertension,
but little is known regarding its adrenal cellular origins. Recently, aldosterone-producing cell …

Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan

Y Ohno, M Sone, N Inagaki, T Yamasaki, O Ogawa… - …, 2018 - Am Heart Assoc
There have been several clinical studies examining the factors associated with
cardiovascular disease (CVD) in patients with primary aldosteronism (PA); however, their …

Long term outcome of aldosteronism after target treatments

VC Wu, SM Wang, CH Chang, YH Hu, LY Lin… - Scientific Reports, 2016 - nature.com
There exists a great knowledge gap in terms of long-term effects of various surgical and
pharmacological treatments on outcomes among primary aldosteronism (PA) patients. Using …

[HTML][HTML] Case detection and diagnosis of primary aldosteronism–the consensus of Taiwan Society of Aldosteronism

VC Wu, YH Hu, LK Er, RF Yen, CH Chang… - Journal of the Formosan …, 2017 - Elsevier
Background/Purpose Even though the increasing clinical recognition of primary
aldosteronism (PA) as a public health issue, its heightened risk profiles and the availability …

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes

VC Wu, SM Wang, SCJ Chueh, SY Yang, KH Huang… - Scientific reports, 2017 - nature.com
Constitutive activation of the Wnt pathway/β-catenin signaling may be important in
aldosterone-producing adenoma (APA). However, significant gaps remain in our …

Quantitative value of aldosterone‐renin ratio for detection of aldosterone‐producing adenoma: the Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) …

G Maiolino, G Rossitto, V Bisogni, M Cesari… - Journal of the …, 2017 - Am Heart Assoc
Background Current guidelines recommend use of the aldosterone‐renin ratio (ARR) for the
case detection of primary aldosteronism followed by confirmatory tests to exclude false …